Background-Nephrogenic systemic fibrosis (NSF) is an incurable, debilitating disease found exclusively in patients with decreased kidney function and comprises a fibrosing disorder of the skin and systemic tissues. The disease is associated with exposure to Gadolinium based contrast agents (GBCA) used in magnetic resonance imaging (MRI). Tissue samples from many NSF patients contain micron-sized insoluble Gd-containing deposits. However, the precise composition and chemical nature of these particles is unclear.
Introduction
The potentially fatal disease, Nephrogenic Systemic Fibrosis (NSF), is associated with decreased kidney function and exposure to gadolinium-based contrast agents (GBCA) used in magnetic resonance imaging (MRI) 1 , 2 . Scanning electron microscopy/energy dispersive spectroscopy (SEM/EDS) of patient tissues has consistently demonstrated micron-sized insoluble deposits containing Gd together with Ca, P, and Na 3 , 4 . GBCAs are the only significant source of human Gd exposure. As Gd is toxic, they comprise Gd 3+ bound to a chelator designed to both solubilize the metal ion and render it biologically inaccessible. Whether the deposits observed in tissues contain precipitated intact GBCA or mineralized Gd dissociated from the chelating ligand remains an intractable biomedical problem key to understanding the pathogenesis of NSF.
In this paper we use synchrotron x-ray fluorescence (SXRF) microscopy, and extended x-ray absorption fine structure (EXAFS) spectroscopy to chemically characterize the Gd deposits in skin from a NSF patient. SXRF rasters a focused monochromatic x-ray beam across a sample, collecting an x-ray fluorescence spectrum at each point and yielding images showing distributions of specific elements 5 . EXAFS is a structural technique that yields numbers, types and distances of neighbouring atoms around a specific element within a radius of about 6 Å. Fourier transforms of EXAFS spectra are used to visualize atomic structure, as they comprise plots of intensity vs. distance with peaks corresponding to neighbouring atoms 6 .
Materials and Methods
The 64-year-old patient had been diagnosed with end stage renal disease at age 43. While on peritoneal dialysis he had three MRI studies on one day, receiving 180 ml of Optimark ® (Gadoversetamide 0.5 mol/L). NSF symptoms occurred within a few days, and NSF was diagnosed by skin biopsy 4 weeks later. His immediate cause of death 50 months later was multiple organ failure. Autopsy with consent of the family included permission for examination of tissues and access to clinical information for publication.
A formalin-fixed paraffin-embedded skin sample showing Gd deposits and fibrosis typical of NSF was selected. SXRF microscopy on 20 μm sections used Stanford Synchrotron Radiation Lightsource (SSRL) beamline 2-3 with a 2.8 × 2.0 μm beam. Fluorescence intensities were calibrated to element concentrations using appropriate standards (Micromatter). EXAFS measurements on a 3 × 1.5 × 2 mm tissue block used SSRL beamline 7-3. Omniscan™ (gadodiamide) (GE Healthcare) and Magnevist ® (gadopentetate dimeglumine) (Bayer) were diluted to 20 mM Gd before measurement. These GBCAs and OptiMARK ® are structurally analogous as they are all diethylene triamine pentaacetic acid (DTPA) derivatives. EXAFS analysis employed EXAFSPAK software 7 . Detailed methods are in the supporting information. Figure 1 summarizes the microscopy results. Additional information is presented in Figures  S1 to S4 in the supporting information. The tissue shows typical histopathology of NSF 4 . The area studied by SXRF comprises a subcutaneous fat lobule surrounded by fibrotic bands. SEM reveals the presence of insoluble deposits while SEM/EDS confirms Gd associated with P, Ca and Na ( Figure S1 ). The Gd SXRF image shows Gd deposits throughout the tissue especially surrounding the fat lobule. The maximum observed Gd concentration was 0.41 gcm -3 with mean and median Gd densities of 0.011 gcm -3 and 0.0012 gcm -3 respectively. The median concentration compares well with published gravimetric data 8 . With the exception of a large Ca-rich region containing little Gd, the Gd, Ca and P images show almost identical distributions (see Figure S2 ) and analyses of the xray fluorescence intensities show a consistent ratio Gd : Ca : P of 1.0 : 0.43 : 1.6 when Gd is present (the P quantitation has ± 0.5 error). Other metals, such as Zn, are present at low concentrations (< 0.035 per Gd). These show no such trend, with the Zn image revealing an inhomogeneous distribution of Zn throughout the Gd and Ca deposits.
Results

Microscopy
EXAFS Spectroscopy
The Gd EXAFS from the skin sample is very different from those of the GBCAs and analysis indicates that tissue bound Gd is coordinated by phosphate. Figure 2 compares the Gd EXAFS spectra, Fourier transforms and simulations. Table 1 
Discussion
These SXRF microscopy and EXAFS data provide the first atomic scale constraints on the molecular structure of these Gd deposits in an NSF tissue sample. The SXRF microscopy data show a strong correlation between Gd, P and Ca. These correlations are similar to those seen by SEM/EDS 4 , 11 and confirm, with substantially greater sensitivity, the co-distribution of Gd and Ca previously reported using secondary ion mass spectrometry (SIMS) 12 and more recently SXRF microscopy 13 , neither of which reported imaging for P. The EXAFS analysis clearly shows Gd present in a GdPO 4 -like structure. Since Ca can substitute Gd sites in hydrated GdPO 4 provided Na or K is also coordinated 9 , 10 , we infer that the observed deposits comprise a predominately Ca x Na x Gd (1-x) PO 4 material.
We conclude that the Gd deposits in this NSF case consist of a Gd-phosphate material, with little or no Gd still coordinated to the original organic chelator. That the structure of these deposits in this patient's skin is representative of those seen in other NSF cases is strongly supported by previously published analyses of thousands of similar deposits in tissues from NSF patients 11 . The enormous thermodynamic stability of Gd phosphate structures (the solubility product for GdPO 4 .H 2 O has been estimated at 10 -14 ) 14 may provide both an explanation for the formation of these deposits and a challenge to chemists and physicians hoping to treat NSF. It appears reasonable that these deposits in NSF are either causally related to the disease or at least represent a marker of release of Gd from the chelated GBCA.
Bullet Points
What's already known about this topic
• Nephrogenic systemic fibrosis (NSF) is an incurable, debilitating disease found exclusively in patients with decreased kidney function and comprises a fibrosing disorder of the skin and systemic tissues.
• NSF is associated with exposure to Gadolinium based contrast agents (GBCA) in MRI procedures.
• Tissue samples from NSF patients contain micron-sized insoluble deposits of Gd with P, Ca, and Na.
• The chemical nature of these particles is unknown.
What does this study add
• SXRF microscopy and EXAFS spectroscopy on skin autopsy samples from an NSF patient show:
-nearly invariant ratios of Gd:Ca and Gd:P in the particles, -Gd is predominately coordinated by phosphate, and not by the GBCA.
• Further evidence for a causal link between release of Gd from the GBCA and NSF.
• State-of-the-art physical chemical analysis has solved an important and previously intractable biomedical problem.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Table 1 Key EXAFS curve fitting parameters. N = number of backscattering atoms. R = interatomic distance. Parameters fixed in the fit are indicated with parentheses. Full parameters are in the supporting information. 
